Alzheimer’s Blood Test for Early Detection

Ariana Wilson and Mark Drlik seated against a white background, wearing lavalier microphones. The woman on the left has long brown curly hair and is wearing a beige cardigan over a taupe top. The man on the right is wearing glasses and a blue button-up shirt. They appear to be engaged in conversation or a video interview.
Resources

Alzheimer’s Blood Test for Early Detection

Sector: Diagnostics
YouTube video thumbnail

In this episode of MedDevice by Design, we explore a groundbreaking shift in how Alzheimer’s disease may soon be diagnosed. Instead of relying on invasive spinal taps or costly PET scans, researchers have developed a blood test that detects key proteins associated with the disease—offering a more accessible and patient-friendly screening method.

A Simpler Diagnostic Pathway

Traditionally, Alzheimer’s diagnosis has required expensive imaging or invasive cerebrospinal fluid collection. This new approach allows patients to have their blood drawn at a standard medical office, with labs analyzing the sample for specific biomarkers. If these proteins are detected, the patient may then be referred for confirmatory tests and begin treatment earlier.

Supporting Earlier Treatment and Better Research

Early detection is crucial for effective treatment. Many Alzheimer’s drugs are more beneficial when administered during the disease’s early stages. This blood test can identify potential patients sooner, improving clinical outcomes. It also helps pharmaceutical companies recruit participants for trials and monitor drug efficacy over time.

Barriers to Widespread Use

While promising, the Alzheimer’s blood test still faces some hurdles. It’s currently a laboratory-developed test (LDT) and has not yet received FDA approval. Because of this, it’s often not covered by insurance and remains a costly out-of-pocket option for most people.

A Look Ahead

The potential impact of this innovation is immense. By making early Alzheimer’s detection more accessible, the test could transform clinical care and research. As approval processes advance and accessibility improves, this technology may reshape how we diagnose and treat neurodegenerative conditions.

Futuristic laboratory with multiple glowing blue cylindrical tanks emitting mist. A red arrow points to one tank. Overlay text reads: ‘Bacta tank. For real?’ in bold white letters on a black background.

Ariana Wilson and Mark Drlik take inspiration from a scene in The Empire Strikes Back to talk about real-world parallels to the Star Wars bacta tank.

An iron lung on the left and a modern medical ventilator on the right, shown against a plain white background. A red arrow points from the iron lung to the ventilator. Bold overlay text reads: ‘Then vs. Now’ in white font on a black background.

In this MedDevice by Design episode, Ariana Wilson and Mark Drlik take us back in time to explore iron lung innovation during the polio epidemic of the 1920s.

A healthcare professional in a sterile gown and gloves holds an endoscope, with a red arrow pointing toward the device. Beside it, a handheld cleaning brush is shown, symbolizing the manual cleaning process. Text overlay reads “Not sterile. Just safe?”

Ariana and Mark examine the complexities of endoscope reprocessing, one of the most difficult tasks in medical device hygiene.

Sterilizing medical devices using various FDA-approved methods - Image showing three medical-related items—a pulse oximeter, surgical scissors, and a catheter with a Luer lock—on a light background. A bold label at the top reads ‘How to sterilize?’ with an arrow pointing to the pulse oximeter, indicating a question about sterilization methods for these devices.

Ariana and Mark walk through FDA-approved options and explain how to select the right one for your product. From metals to plastics and electronics, not all devices can handle the same process.